Nuremberg, Germany

Markus Schmidt


Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Nürnberg, DE (2013 - 2014)
  • Nuremberg, DE (2011 - 2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovator Markus Schmidt: Advancing Clinical Study Compliance

Introduction

Markus Schmidt, an accomplished inventor based in Nuremberg, Germany, has made significant contributions to the field of clinical research through his innovative work. With a total of 11 patents to his name, his inventions focus on improving the quality and compliance of clinical studies, impacting the healthcare and research sectors positively.

Latest Patents

Among his most notable recent inventions is a method and system for measuring the quality of performance and compliance with the protocol of a clinical study. This innovative method facilitates the determination of clinical study compliance by obtaining relevant criteria for the study and accessing stored clinical data. Subsequently, it correlates these criteria with the clinical data to derive a measure of compliance, enhancing the overall integrity of clinical studies.

Career Highlights

Currently, Markus Schmidt serves as an inventor at Siemens Aktiengesellschaft, where his expertise and innovative approach contribute to the company's objectives in advancing technology and health management solutions. His work not only showcases his capacity for innovation but also highlights his commitment to improving clinical processes through effective methodologies.

Collaborations

Throughout his career, Markus has collaborated with esteemed colleagues such as Gudrun Zahlmann and Horst Schreiner. These partnerships have played a vital role in the development and success of his inventions, demonstrating the collaborative nature of innovation in the scientific community.

Conclusion

Markus Schmidt continues to be a pivotal figure in the realm of clinical research innovations. His dedication to improving clinical study compliance through inventive methodologies ensures that he remains at the forefront of advancements in healthcare technology. With his remarkable portfolio of patents, Schmidt is poised to influence the future of clinical studies significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…